
CQC’s new primary care framework: What GP practices should do now
CQC is retiring its single assessment framework for a primary care specific model from late 2026. Here's what's changing for GP practices, and what to do now.
Glossary
Terminal value is the estimated value of a business at the end of a forecast period in a discounted cash flow (DCF) model. It represents the present value of all future cash flows expected beyond the explicit projection horizon.
In a DCF valuation, cash flows are typically projected over a defined period, often five to ten years. Terminal value captures the continuing value of the business after that forecast period, when detailed projections are no longer modelled individually.
In practice, terminal value frequently accounts for a significant proportion of total DCF output, particularly in growth-oriented businesses. As a result, small changes in assumptions can materially affect the overall valuation.
There are two principal approaches to estimating terminal value. The perpetuity growth method assumes cash flows continue indefinitely at a stable growth rate. The exit multiple method applies a valuation multiple, such as EBITDA, to the final forecast year.
Terminal value is then discounted back to present value using the model’s discount rate, typically reflecting the company’s weighted average cost of capital.
A UK manufacturing company prepares a five-year DCF model as part of a valuation exercise. At the end of year five, it applies a 2% perpetual growth rate to forecast free cash flow to calculate terminal value. That terminal value represents more than half of the total enterprise value once discounted to present value.
Terminal value does not represent the expected sale price on a specific future date.
Terminal value does not assume high growth continues indefinitely.
Terminal value does not remove the need for detailed short-term forecasting.
Because it captures all cash flows beyond the explicit forecast period, which may extend indefinitely, it often accounts for a large share of total calculated value.
The two most common methods are the perpetuity growth approach and the exit multiple approach. Both rely on assumptions about future performance and market conditions.
Terminal value is highly sensitive to changes in long-term growth rates, discount rates and final-year financial metrics, which can materially affect overall valuation results.
No. Terminal value is calculated at the end of the forecast period and is then discounted to determine its present value within the DCF model.
We always recommend that you seek advice from a suitably qualified adviser before taking any action. The information in this glossary entry only serves as a guide and no responsibility for loss occasioned by any person acting or refraining from action as a result of this material can be accepted by the authors or the firm.
Contact us today to find out more about how we can help you

CQC is retiring its single assessment framework for a primary care specific model from late 2026. Here's what's changing for GP practices, and what to do now.

How Price Bailey supports NRG Therapeutics with investor-led audit and governance advice as it transitions from discovery-stage research to clinical development...

Stay up-to-date with the data and stories emerging from UK valuations.

Tax Investigations Partner, Andrew Park, provides a round up of the most recent and significant contentious tax news. Read more here...